Viking Thera (VKTX)
23.91 -0.24 (-0.99%) 04/01/25 [NASDAQ]
23.56 x 100 23.76 x 100
Realtime by (Cboe BZX)
23.56 x 100 23.76 x 100
Realtime 23.75 -0.16 (-0.67%) 07:00 ET
for Tue, Apr 1st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,963 | -85,895 | -68,867 | -54,990 | -39,495 |
| Depreciation Amortization | -16,827 | -7,822 | 1,567 | 4,220 | 4,191 |
| Accounts payable and accrued liabilities | 2,303 | -1,018 | 7,085 | -2,544 | 1,555 |
| Other Working Capital | 9,362 | 3,548 | 10,189 | -2,927 | 7,717 |
| Other Operating Activity | 27,335 | 17,811 | 1,629 | 8,655 | 4,255 |
| Operating Cash Flow | $-87,790 | $-73,376 | $-48,397 | $-47,586 | $-21,777 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -553,366 | -179,086 | 54,753 | 37,960 | 41,567 |
| Investing Cash Flow | $-553,366 | $-179,086 | $54,753 | $37,960 | $41,567 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,813 | 6,768 | 848 | 7,633 | 1,272 |
| Common Stock Repurchased | N/A | N/A | -6,795 | N/A | N/A |
| Other Financing Activity | 601,651 | 264,608 | 10,110 | -753 | -322 |
| Financing Cash Flow | $612,464 | $271,376 | $4,163 | $6,880 | $950 |
| Exchange Rate Effect | -148 | -30 | -258 | N/A | N/A |
| Beginning Cash Position | 55,516 | 36,632 | 26,371 | 29,117 | 8,377 |
| End Cash Position | 26,676 | 55,516 | 36,632 | 26,371 | 29,117 |
| Net Cash Flow | $-28,840 | $18,884 | $10,261 | $-2,746 | $20,740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,790 | -73,376 | -48,397 | -47,586 | -21,777 |
| Free Cash Flow | -87,790 | -73,376 | -48,397 | -47,586 | -21,777 |